Literature DB >> 26227172

An Investigation of the Utility of the Addenbrooke's Cognitive Examination III in the Early Detection of Dementia in Memory Clinic Patients Aged over 75 Years.

Michael T Jubb1, Jonathan J Evans.   

Abstract

BACKGROUND/AIMS: To examine the validity of Addenbrooke's Cognitive Examination III (ACE-III) in detecting early dementia in UK memory clinic patients aged 75-85 years.
METHODS: The ACE-III was administered to 59 patients prior to diagnosis. The extent to which scores predicted the membership of the dementia or no-dementia group was explored using receiver operating characteristic curve analysis and other parameters of diagnostic performance. Thirty-three participants (55.9%) were diagnosed with dementia (Alzheimer's disease = 56.3%, Alzheimer's disease with cerebrovascular disease = 31.3%, and vascular dementia = 12.5%).
RESULTS: The optimal cut-off for detecting dementia was 81/100 (scores <81 indicating dementia with a sensitivity of 0.79, a specificity of 0.96, and a positive predictive value of 0.96), with superiority over published cut-offs (88/100 and 82/100) at medium and lower prevalence rates. The number of years of full-time education had a significant positive relationship to total ACE-III scores (r = 0.697, p < 0.001) for the no-dementia group. Exploratory analysis indicated that optimal cut-offs were different for higher versus lower education groups.
CONCLUSIONS: The ACE-III has excellent accuracy for the detection of dementia in day-to-day clinical practice. Lower cut-offs than those specified in the index paper, and the consideration of the patients' years of full-time education may be necessary for optimal diagnostic performance.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2015        PMID: 26227172     DOI: 10.1159/000433522

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  3 in total

1.  Addenbrooke's Cognitive Examination III (ACE-III) and mini-ACE for the detection of dementia and mild cognitive impairment.

Authors:  Lucy C Beishon; Angus P Batterham; Terry J Quinn; Christopher P Nelson; Ronney B Panerai; Thompson Robinson; Victoria J Haunton
Journal:  Cochrane Database Syst Rev       Date:  2019-12-17

Review 2.  Addenbrooke's cognitive examination III in the diagnosis of dementia: a critical review.

Authors:  Diana Bruno; Sofia Schurmann Vignaga
Journal:  Neuropsychiatr Dis Treat       Date:  2019-02-15       Impact factor: 2.570

3.  Spatial variation of perfusion MRI reflects cognitive decline in mild cognitive impairment and early dementia.

Authors:  Catherine A Morgan; Tracy R Melzer; Reece P Roberts; Kristina Wiebels; Henk J M M Mutsaerts; Meg J Spriggs; John C Dalrymple-Alford; Tim J Anderson; Nicholas J Cutfield; Gerard Deib; Josef Pfeuffer; Donna Rose Addis; Ian J Kirk; Lynette J Tippett
Journal:  Sci Rep       Date:  2021-12-02       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.